Nomura Micro Science Co., Ltd. Q1 FY2027 Analysis: Strong Full-Year Guidance Signals Cycle Rebound
Nomura Micro Science Co., Ltd. (TSE:6254), a major provider of ultra-pure water systems critical to the semiconductor and pharmaceutical industries, reported significant year-over-year declines in its first quarter (Q1) results for the fiscal year ending March 2027. Despite the Q1 contraction across revenue and profitability metrics, management has issued an aggressive full-year forecast, signaling strong expectations for a substantial rebound driven by anticipated large-scale equipment installations in the latter half of the fiscal year.
| Metric | Current Period (JPY) | Prior Period (JPY) | YoY Change |
|---|---|---|---|
| Revenue | JPY 9.20bn | N/A | -25.8% |
| Operating Profit | JPY 628M | N/A | -54.4% |
| Ordinary Income | JPY 342M | N/A | -56.2% |
| Net Profit | JPY 239M | N/A | -48.4% |
| Operating Margin | 6.8% | N/A | N/A |
Nomura Micro Science Co., Ltd. specializes in providing advanced ultra-pure water treatment systems, serving as a foundational supplier to high-tech manufacturing sectors such as semiconductors and pharmaceuticals. The company maintains an established foothold across Asia, with ongoing expansion efforts noted in markets including South Korea and Taiwan.
The Q1 figures reflect a direct impact from the cyclical nature of its core business; revenue declined by 25.8% year-over-year (YoY), leading to substantial drops in Operating Profit (-54.4%) and Net Profit (-48.4%). This downturn is attributed primarily to a temporary slowdown or completion cycle among major equipment orders from key semiconductor clients. However, the resilience of its service revenue stream—derived from maintenance and consumables—provided a stabilizing element, contributing to an improved Operating Margin of 6.8%.
The most salient takeaway for international investors is the contrast between the weak Q1 performance and the highly optimistic full-year guidance. Management’s forecast anticipates robust growth across the board, suggesting that the current quarter’s dip is viewed as a temporary cyclical trough rather than a structural decline in demand. Furthermore, while the core business relies on large capital expenditure cycles, the company highlighted an extremely high YoY increase in order intake (783.4% YoY), which serves as a powerful leading indicator for future revenue realization.
Full-Year Guidance
| Metric | Forecast (JPY) | Prior Period Comparison | YoY Change |
|---|---|---|---|
| Revenue | JPY 97.0bn | N/A | +72.5% |
| Operating Profit | JPY 16.0bn | N/A | +140.0% |
| Ordinary Income | JPY 15.0bn | N/A | +166.5% |
| Net Profit | JPY 11,100M | N/A | +190.7% |
The full-year guidance indicates highly ambitious growth targets, suggesting management anticipates a significant recovery in the second half of the fiscal year to offset the Q1 softness. The forecast for Operating Profit (JPY 16.0bn) implies substantial margin expansion relative to prior periods.
Key Points for Investors to Monitor:
- Order Book Conversion: The market will be closely watching the conversion rate of the massive order intake into recognized revenue and profit in H2. This remains the most critical near-term indicator.
- Profitability Maintenance: While top-line recovery is expected, investors should monitor cost management. As sales rebound, maintaining profitability requires effectively scaling operational expenditures (SG&A) to match the projected high growth rates.
- Strategic Focus Areas: The company’s stated focus on “profitability improvement” and “capital efficiency” suggests a strategic pivot toward higher-margin service contracts alongside large equipment sales, which should be tracked in future reporting.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Financial figures are AI-extracted and may contain errors — always verify against the original filing.